ACN vs NXL · P/E 24, rev $17.60B vs rev $301.6K
Accenture plc (ACN) versus Nexalin Technology Inc. (NXL) — a side-by-side from cached financials, not a winner call.
Accenture plc (ACN) is a information technology services company listed on US.
Nexalin Technology Inc. (NXL) is a medical devices company listed on NASDAQ.
Latest reported ACN revenue for 2025-08-31 was $17.60B. Net income was $1.41B. Revenue was down 0.7% from 2025-05-31 to 2025-08-31. ACN currently screens at market cap $186.16B and trailing P/E 23.8.
Latest reported NXL revenue for 2025-12-31 was $301.6K. Net income was -$8.2M. Revenue was up 78.8% from 2024-12-31 to 2025-12-31. NXL currently screens at market cap $8.5M.
ACN currently screens at market cap $186.16B and trailing P/E 23.8. NXL currently screens at market cap $8.5M.
Not investment advice. Open the ACN and NXL stock pages for the full models.
Not investment advice.